As some of you know, my son Andrew was diagnosed with stage 3 intermediate-risk neuroblastoma when he was 6 months old. He is now 7 and thriving. Fifteen years ago, the survival rate of high-risk neuroblastoma was 10%. A group of parents, many of whom were struggling financially, banded together and worked extremely hard to raise the $2 million needed for Dr. Cheung at Memorial Sloan Kettering to develop an antibody that he believed would be promising. All the while knowing that their children would not survive long enough for the research to be complete. Today, due to the success of Dr. Cheung’s antibody research, over 60 percent of children with high-risk neuroblastoma survive. Please join me in donating to MSK in order to help fund neuroblastoma research that could save the additional 40 percent. Pediatric cancer is significantly underfunded because it is so rare. No amount is too small.